Shamburg News · 8-K filed Nov 6, 2026, 8:30 AM EST
BioCardia Completes PMDA Clinical Consultation for CardiAMP in Japan
BCDA · BioCardia, Inc.
- Other event
- Materiality: medium
On November 6, 2026, BioCardia, Inc. announced it completed the consultation process with Japan's PMDA concerning application materials for CardiAMP Cell Therapy System for ischemic heart failure. The company stated this advances it toward submission of a marketing approval application in Japan. Completion of the consultation does not constitute regulatory approval, and the product remains subject to PMDA review.
Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001437749-26-035408.
Written from the filing by Shamburg Markets. Figures are as reported by the company.